首页> 外文期刊>Journal of Applied Biomaterials & Functional Materials >Titanium-hydroxyapatite composites sintered at low temperature for tissue engineering: in vitro cell support and biocompatibility
【24h】

Titanium-hydroxyapatite composites sintered at low temperature for tissue engineering: in vitro cell support and biocompatibility

机译:钛 - 羟基磷灰石复合材料在低温下烧结组织工程:体外细胞支持和生物相容性

获取原文
获取原文并翻译 | 示例
           

摘要

Background: In clinical orthopedics, a critical problem is the bone tissue loss produced by a disease or injury. The use of composites from titanium and hydroxyapatite for biomedical applications has increased due to the resulting advantageous combination of hydroxyapatite bioactivity and favorable mechanical properties of titanium. Powder metallurgy is a simple and lower-cost method that uses powder from titanium and hydroxyapatite to obtain composites having hydroxyapatite phases in a metallic matrix. However, this method has certain limitations arising from thermal decomposition of hydroxyapatite in the titanium-hydroxyapatite system above 800 degrees C. We obtained a composite from titanium and bovine hydroxyapatite powders sintered at 800 degrees C and evaluated its bioactivity and cytocompatibility according to the ISO 10993 standard.
机译:背景:在临床骨科中,关键问题是疾病或损伤产生的骨组织损失。 由于羟基磷灰石生物活性和钛的有利机械性能,因此使用来自钛和羟基磷灰石用于生物医学应用的复合材料的使用增加了。 粉末冶金是一种简单且低成本的方法,使用来自钛和羟基磷灰石的粉末,得到金属基质中具有羟基磷灰石相的复合材料。 然而,该方法具有从800℃的钛 - 羟基磷灰石体系中的羟基磷灰石的热分解产生的一定限制。我们得到了在800℃下烧结的钛和牛羟基磷灰石粉末的复合物,并根据ISO 10993评价其生物活性和细胞粘合性。 标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号